Health 
   Chronic & Non-communicable Diseases
Cancer
Post-Doctoral Fellowships
France
The role of the p53 mRNA-Mdm2 interaction in controlling the DNA damage response
 My research focuses on the protein p53, a key mediator of the DNA damage response which controls genome stability and cancer development. My aim is to verify the importance of the p53 mRNA (messenger RNA) – Mdm2 interaction in controlling the protein Mdm2 and p53 functions. This study holds promise to offer a viable explanation to why induction of Mdm2 by p53 in response to DNA damage leads to an actual increase in p53 activity and not to p53 inactivation. 
 To add or modify information on this page, please contact us at the following address: community.research@axa.com 
  Marco
 CANDEIAS 
Institution
Institut National de la Santé et de la Recherche Médicale
Cancer Institute
Country
France
Nationality
Portuguese
Related articles
 Health 
   Chronic & Non-communicable Diseases
Medical Treatment & Drug Development
Chronic Pain & Musculoskeletal Disorders
Drug Delivery
Biotech- and Nanotechnology
AXA Project
France
Pain Pediatric & Elderly AXA Research Lab (PEARL)
Chronic pain is recognized as a major public health problem affecting patients in their daily activity, physical and mental health,... Read more
 Celine
 GRECO